First Faculty of Medicine, Institute of Inherited Metabolic Disorders, Charles University in Prague and General University Hospital in Prague, Czech Republic.
Mol Genet Metab. 2012 Nov;107(3):611-3. doi: 10.1016/j.ymgme.2012.08.014. Epub 2012 Aug 23.
We report on the seventh known patient with S-adenosylhomocysteine hydrolase (SAHH) deficiency presenting at birth with features resembling phosphomannomutase 2 (PMM2-CDG Ia) deficiency. Plasma methionine and total homocysteine levels were normal at 2 months and increased only after the 8th month of age. SAHH deficiency was confirmed at 4.5 years of age by showing decreased SAHH activity (11% in both erythrocytes and fibroblasts), and compound heterozygosity for a known mutation c.145C>T (p.R49C) and a novel variant c.211G>A (p.G71S) in the AHCY gene. Retrospective analysis of clinical features revealed striking similarities between SAHH deficiency and the PMM2-CDG Ia.
我们报告了第七例腺苷同型半胱氨酸水解酶(SAHH)缺乏症患者,该患者出生时表现出类似于磷酸甘露糖变位酶 2(PMM2-CDG Ia)缺乏症的特征。2 个月时,血浆蛋氨酸和总同型半胱氨酸水平正常,仅在 8 个月后才升高。4.5 岁时,通过显示 SAHH 活性降低(红细胞和成纤维细胞均为 11%),以及 AHCY 基因中已知突变 c.145C>T(p.R49C)和新的变异 c.211G>A(p.G71S)的复合杂合性,确诊为 SAHH 缺乏症。回顾性分析临床特征表明,SAHH 缺乏症与 PMM2-CDG Ia 之间存在显著相似性。